A carregar...
Effects of Tenapanor on Cytochrome P450‐Mediated Drug‐Drug Interactions
Tenapanor (RDX5791, AZD1722) is an inhibitor of sodium/hydrogen exchanger isoform 3 in development for the treatment of constipation‐predominant irritable bowel syndrome and the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis. We aimed to investigate whether tenapa...
Na minha lista:
| Publicado no: | Clin Pharmacol Drug Dev |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5599994/ https://ncbi.nlm.nih.gov/pubmed/28301096 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.346 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|